Division of Vascular and Endovascular Surgery, the Ottawa Hospital and the University of Ottawa, Ottawa, Ontario, Canada.
J Vasc Surg. 2012 Dec;56(6):1518-26, 1526.e1. doi: 10.1016/j.jvs.2012.05.102. Epub 2012 Oct 13.
While randomized trials have shown improved operative mortality with endovascular aneurysm repair (EVAR) but similar long-term mortality rates, enthusiasm for EVAR persists, and rates of EVAR use continue to increase. Currently, knowledge of utilization rates of EVAR in Canada is limited.
Patients who underwent nonruptured abdominal aortic aneurysm (AAA) and ruptured AAA (RAAA) repair, by either open surgical repair (OSR) or EVAR, in Canada were identified from hospital discharge abstract data. Trends in rates for OSR and EVAR were calculated by province and by year, and standardized per 100,000 persons over 65 years of age (per capita).
Between April 2004 and March 2009, 15,960 AAA procedures were performed in Canada, either by OSR (n=12,204) or EVAR (n=3756). The proportion of all elective AAA procedures by EVAR increased from 11.5% in 2005 to 35.5% in 2009, the highest current proportion of EVAR utilization in British Columbia (45.0%) and the lowest in Manitoba (15.8%). After standardization, the national rate of total procedures was steady, but the rate of RAAAs declined over the entire study period. Alberta consistently had the highest per capita rates of EVAR use (38.9), whereas Prince Edward Island had the lowest (8.4). Provincial variations in EVAR use did not correlate with differences in comorbidities. Compared with Canadian averages, Atlantic Provinces performed the most AAA procedures per capita (137.5 vs 93.4), had the highest rate of RAAAs per capita (29.7 vs 22.2), and had the lowest proportional rates of EVAR use.
Use of EVAR in Canada for AAAs has increased in the past 5 years, without affecting overall AAA procedure volumes. Large discrepancies in EVAR use exist across Canada. The Atlantic Provinces had the highest rates of RAAAs despite having the highest rates for total AAA procedures, suggesting a population with higher susceptibility for AAAs. This region may also have the largest potential for future increased use of EVAR.
尽管随机试验表明血管内动脉瘤修复术(EVAR)可降低手术死亡率,但长期死亡率相似,因此 EVAR 仍受到青睐,其使用率持续上升。目前,加拿大 EVAR 使用情况的相关知识有限。
本研究从医院出院摘要数据中确定了在加拿大接受非破裂性腹主动脉瘤(AAA)和破裂性 AAA(RAAA)修复的患者,这些患者接受的治疗分别为开放手术修复(OSR)或 EVAR。按省份和年份计算 OSR 和 EVAR 的使用率,并按每 10 万 65 岁以上人口(人均)标准化。
2004 年 4 月至 2009 年 3 月,加拿大共进行了 15960 例 AAA 手术,其中 OSR 治疗 12204 例,EVAR 治疗 3756 例。EVAR 治疗的所有择期 AAA 手术比例从 2005 年的 11.5%增加到 2009 年的 35.5%,BC 省目前 EVAR 使用率最高(45.0%),曼尼托巴省最低(15.8%)。标准化后,全国手术总例数保持稳定,但整个研究期间 RAAA 例数下降。艾伯塔省 EVAR 使用率一直最高(38.9),而爱德华王子岛最低(8.4)。EVAR 使用的省级差异与合并症的差异无关。与加拿大平均水平相比,大西洋省份的人均 AAA 手术量最多(137.5 比 93.4),人均 RAAA 发生率最高(29.7 比 22.2),EVAR 使用率最低。
过去 5 年,加拿大 EVAR 在治疗 AAA 方面的应用有所增加,并未影响整体 AAA 手术量。加拿大各地 EVAR 使用情况存在较大差异。尽管大西洋省份的总 AAA 手术量最高,但 RAAA 发生率最高,这表明该人群 AAA 的易感性更高。该地区可能也有未来更多使用 EVAR 的潜力。